Prognostic Prediction of BRCA Mutations by F-18-FDG PET/CT SUVmax in Breast Cancer

Creative Commons License

ÖZDEMİR S., SILAN F., Akgun M. Y., Araci N., Cirpan I., Ozturk F. K., ...Daha Fazla

MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, cilt.30, sa.3, ss.158-168, 2021 (ESCI) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 30 Sayı: 3
  • Basım Tarihi: 2021
  • Doi Numarası: 10.4274/mirt.galenos.2021.82584
  • Dergi Adı: MOLECULAR IMAGING AND RADIONUCLIDE THERAPY
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.158-168
  • Anahtar Kelimeler: BRCA1-2 mutation, SUVmax, F-18-FDG PET/CT, breast cancer, ESTROGEN, RISK, SURVIVAL, KI-67
  • Çanakkale Onsekiz Mart Üniversitesi Adresli: Evet

Özet

Objectives: This study aimed to investigate the prognostic prediction of germline BRCA1 and BRCA2 mutations by comparing the maximum standardized uptake value (SUVmax) obtained from (18)fluoride-fluorodeoxyglucose positron emission tomography/computed tomography (F-18-FDG PET/CT), which is considered a prognostic factor in breast cancer (BC).